Business trending topics
2,240 results
Bristol Myers Squibb (NYSE: BMY)‘s stock had its “market perform” rating reiterated by analysts at Sanford C. Bernstein in a research report issued to clients and investors on Tuesday, StockRatingsNetwork.com reports. They currently have a ...watchlistnews.com · 16 hours ago
Bristol-Myers Squibb (NYSE: BMY ) is preparing two doses of cash for its shareholders. The pharmaceutical giant has declared a quarterly common stock dividend of $0.35 per share, to be handed out on Aug. 1 to …The Motley Fool · ByEric Volkman · 6 hours ago
resource.uk.com
Investors considering a purchase of Bristol-Myers Squibb Bristol-Myers Squibb Co. (NYSE: BMY) stock, but tentative about paying the going market price of $47.16/share, might benefit from considering selling puts among …Forbes · 6/14/2013
In-depth coverage
They now have a $45.00 price target on the stock. On a related note, analysts at UBS AG raised their price target on shares of Bristol Myers Squibb from $40.00 to $48.00 in a research note to investors on Tuesday …Daily Political · ByTyrone Williams · 6 hours ago
The company recently announced encouraging Phase I testing data on the drug nivolumab ... In the latest quarter, Bristol posted net sales of $3.9 billion, a decrease of 27% compared to the same period a year ago. The …INSIDER MONKEY · 6/17/2013
Bristol Myers Squibb (NYSE: BMY)‘s stock had its “market perform” rating reiterated by analysts at Sanford C. Bernstein in a research report issued to clients and investors on Tuesday, ARN reports. They currently have a $45.00 price ...mideasttime.com · 1 day ago
NEW YORK--(BUSINESS WIRE)-- The Board of Directors of Bristol-Myers Squibb Company (NYSE: BMY ) today declared a quarterly dividend of thirty-five cents ($0.35) per share on the $0.10 par value Common Stock of …The Motley Fool · 8 hours ago
In-depth coverageBristol-Myers Squibb Company (BMY) and partner AbbVie Inc. (ABBV) recently presented data on their oncology candidate, elotuzumab, from a phase II study. Results were presented at the annual meeting of the European Hematology Association held in …Investopedia · 6/17/2013
Bristol-Myers Squibb (NYSE:BMY) has opened bearishly below the pivot of $46.77 today and has reached the first level of support at $46.54. Investors may be interested in a cross of the next downside pivot targets of $46.23 and $45.69. Bristol-Myers …Comtex Smartrend · ByAmy Schwartz · 14 hours ago
In order to become successful, you need to have information as it happens and understand how it plays out into future stock price. This is our expertise ... d=2013-06-18&s=FSLR-NWSA-BMY-LULU First Solar, Inc. (NASDAQ: FSLR) Did you want to hear …Stockhouse · 1 day ago
- © 2013 Microsoft |
- Privacy and Cookies |
- Legal |
- Advertise |
- About our ads |
- Help |
- Feedback